Results 151 to 160 of about 2,502 (176)
Some of the next articles are maybe not open access.
International Journal of Dermatology, 1991
Abstract: An open, comparative, randomized study was conducted using griseofulvin or itraconazole for the treatment of onychomycosis of the foot. Group I (45 patients) received itraconazole and Group II (45 patients) received griseofulvin. Each group was divided into three subgroups that received different topical treatment: antimycotic cream ...
R, Arenas, G, Fernández, L, Domínguez
openaire +2 more sources
Abstract: An open, comparative, randomized study was conducted using griseofulvin or itraconazole for the treatment of onychomycosis of the foot. Group I (45 patients) received itraconazole and Group II (45 patients) received griseofulvin. Each group was divided into three subgroups that received different topical treatment: antimycotic cream ...
R, Arenas, G, Fernández, L, Domínguez
openaire +2 more sources
Drug Research, 2013
Topical keratolytic agents such as benzoyl peroxide (BP) and salicylic acid (SA) are one of the common treatments for inflammatory skin diseases. However, the amount of drug delivery through the skin is limited due to the stratum corneum. The purposes of this study were to investigate the ability of fish oil to act as penetration enhancer for topical ...
K, Rehman, C M, Tan, M H, Zulfakar
openaire +2 more sources
Topical keratolytic agents such as benzoyl peroxide (BP) and salicylic acid (SA) are one of the common treatments for inflammatory skin diseases. However, the amount of drug delivery through the skin is limited due to the stratum corneum. The purposes of this study were to investigate the ability of fish oil to act as penetration enhancer for topical ...
K, Rehman, C M, Tan, M H, Zulfakar
openaire +2 more sources
Journal of the European Academy of Dermatology and Venereology, 2010
AbstractBackground Increasing antibiotic resistance of Propionibacterium acnes and growing awareness on the side effects of topical and systemic drugs in the treatment of acne vulgaris by physicians and patients have paved the way for a search into new efficacious and safe treatment modalities such as photodynamic therapy (PDT).
Leeuw, Jaap +3 more
openaire +3 more sources
AbstractBackground Increasing antibiotic resistance of Propionibacterium acnes and growing awareness on the side effects of topical and systemic drugs in the treatment of acne vulgaris by physicians and patients have paved the way for a search into new efficacious and safe treatment modalities such as photodynamic therapy (PDT).
Leeuw, Jaap +3 more
openaire +3 more sources
Journal of Clinical Oncology, 2010
9017 Background: HFS is a dose-limiting toxicity of capecitabine, occurring in 43-71% of patients. No effective preventative treatment has been definitively demonstrated.
S. L. Wolf +9 more
openaire +1 more source
9017 Background: HFS is a dose-limiting toxicity of capecitabine, occurring in 43-71% of patients. No effective preventative treatment has been definitively demonstrated.
S. L. Wolf +9 more
openaire +1 more source
Improving the outcome for children with cancer: Development of targeted new agents
Ca-A Cancer Journal for Clinicians, 2015Peter C Adamson
exaly
[An unknowed keratolytic agent: urea].
Bulletin de la Societe francaise de dermatologie et de syphiligraphie, 1972openaire +1 more source
[Salicylic acid as a keratolytic agent].
Annales de dermatologie et de venereologie, 2002openaire +1 more source
[Alginates as keratolytic agents in local dermatological therapy].
Minerva dermatologica, 1970openaire +1 more source